Brivaracetam
(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
Molecular Identity
Brivaracetam
(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
PubChem CID: 9837243
Brivaracetam is a non-proteinogenic amino acid derivative that is butanamide in which the pro-S hydrogen at position 2 is replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl. Used for treatment of partial onset seizures related to epilepsy. It has a role as an anticonvulsant. It is a gamma-lactam and a non-proteinogenic amino acid derivative. It is functionally related to a L-alpha-aminobutyric acid.
2D Structure
Properties
C11H20N2O2
Molecular Formula
212.29
Molecular Weight
g/mol
212.1525
Exact Mass
Da
1
XLogP
Drug-like (Lipinski: < 5)
63.4
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
2
H-Bond Acceptors
253
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Brivaracetam357336-20-0BriviactUCB 34714UCB-34714UCB34714(2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-yl]butanamideU863JGG2IA1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-CHEBI:133013DTXSID00905081(2S)-2-((4R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamidebrivaracetamumRefChem:57048N03AX23
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Brivaracetam
Loading drug network...